Acute Lymphoblastic Leukemia (ALL)
Also known as: Lymphoblastic Leukemia, Acute / Leukemia Lymphoblastic, Acute / Leukaemia (Acute Lymphoblastic) / Leukemia, Lymphoblastic, Acute / Acute Lymphoblastic Leukaemias (ALL) / Acute Leukaemia, Lymphoblastic / Acute Lymphoblastic Leukaemia / Acute Leukemia, Lymphoblastic / Acute Lymphoblastic Leukemia(ALL) / Leukemia, Lymphoblastic (Acute) / ALL (Acute Lymphoblastic Leukemia) / Acute Lymphoblastic Leukemia / Leukaemia, Lymphoblastic, Acute / Acute Lymphoblastic Leukemias / Acute Lymphoblastic Leukemia ALL / Leukemia, Acute Lymphoblastic / Acute Lymphatic Leukemia / Acute Lymphocytic Leukemia / Acute Lymphocytic Leukaemia / Lymphocytic Leukemia, Acute / Leukemia Acute Lymphoid Leukemia (ALL) / Acute,Leukemia, Lymphoid / Acute Leukemia, Lymphoid / Leukemia, Acute Lymphocytic / Acute Leukemia, Lymphocytic / Acute Lymphocytic Leukemia (ALL) / Acute Lymphoid Leukemia / Leukemia, Lymphoid, Acute / Leukemia, Acute Lymphocytic (ALL) / Acute Lymphoid Leukemia (ALL) / Leukemia, Lymphocytic, Acute / All / Acute lymphoblastic leukemia with failed remission / Leukemia lymphoblastic acute / Lymphoid leukaemia, acute / Acute lymphoid leukaemia / Lymphoid leukemia, acute / Acute lymphoid leukemia, disease (disorder) / [M]Acute lymphoid leukaemia / [M]Acute lymphoid leukemia (morphologic abnormality) / Acute lymphoblastic leukemia [ALL] / Leukaemia lymphoblastic acute / Acute lymphatic leukaemia / Leukaemias acute lymphocytic / Precursor cell lymphoblastic leukemia (morphologic abnormality) / Acute lymphoblastic leukemia -RETIRED-
| Drug | Drug Name | Drug Description |
|---|---|---|
| DB08886 | Asparaginase Erwinia chrysanthemi | An asparagine-specific enzyme used as part of a chemotherapeutic regimen to treat patients with acute lymphoblastic leukemia and lymphoblastic lymphoma. |
| DB00023 | Asparaginase Escherichia coli | An asparaginase enzyme from E. coli used as part of treatment regimens for acute lymphoblastic leukemias. |
| DB14730 | Calaspargase pegol | An asparagine specific enzyme used to treat acute lymphoblastic leukemia. |
| DB00531 | Cyclophosphamide | A nitrogen mustard used to treat lymphomas, myelomas, leukemia, mycosis fungoides, neuroblastoma, ovarian adenocarcinoma, retinoblastoma, and breast carcinoma. |
| DB00987 | Cytarabine | A pyrimidine nucleoside analogue used to treat acute non-lymphocytic leukemia, lymphocytic leukemia, and the blast phase of chronic myelocytic leukemia. |
| DB01254 | Dasatinib | A tyrosine kinase inhibitor used for the treatment of lymphoblastic or chronic myeloid leukemia with resistance or intolerance to prior therapy. |
| DB00694 | Daunorubicin | An anthracycline aminoglycoside used to induce remission of nonlymphocytic leukemia and acute lymphocytic leukemia. |
| DB00997 | Doxorubicin | A medication used to treat various cancers and Kaposi's Sarcoma. |
| DB00773 | Etoposide | A podophyllotoxin derivative used to treat testicular and small cell lung tumors. |
| DB01033 | Mercaptopurine | An antineoplastic agent used to treat acute lymphocytic leukemia. |
| DB00563 | Methotrexate | An antineoplastic agent used the treatment of a wide variety of cancers as well as severe psoriasis, severe rheumatoid arthritis, and juvenile rheumatoid arthritis. |
| DB01204 | Mitoxantrone | A chemotherapeutic agent used for the treatment of secondary progressive, progressive relapsing, or worsening relapsing-remitting multiple sclerosis. |
| DB00059 | Pegaspargase | A modified form of L-asparagine amidohydrolase used to treat acute lymphoblastic leukemia, which is dependent on an external source of asparagine. |
| DB08901 | Ponatinib | A kinase inhibitor used to treat patients with various types of chronic myeloid leukemia (CML). |
| DB00541 | Vincristine | A vinca alkaloid used to treat acute leukemia, malignant lymphoma, Hodgkin's disease, acute erythraemia, and acute panmyelosis. |
| DB00309 | Vindesine | A vinca alkaloid derived from vinblastine used for various types of malignancies, but mainly acute lymphocytic leukemia (ALL). |